Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

QGEN Company Profile and Key Details

NYSE : QGEN

Qiagen N.V.

$38.94
0.368+0.95%
Open: 12:21 PM
55.16
B-ESG ScoreESG Rating

QGEN Stock Price Chart

Stock Price Today

Qiagen N.V. (QGEN) stock surged +0.95%, trading at $38.94 on NYSE, up from the previous close of $38.57. The stock opened at $39.17, fluctuating between $38.85 and $39.46 in the recent session.

Stock Snapshot

38.57
Prev. Close
39.17
Open
8.48B
Market Cap
217.68M
Number of Shares
38.85
Day Low
39.46
Day High
102.47
P/E Ratio
99.52%
Free Float in %
0.38
EPS (TTM)
17.2
Book Value
1.34
Cash Flow per Share
319.54K
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 20, 202539.2039.4338.4938.571.12M
Feb 19, 202539.3639.4239.0239.22915.2K
Feb 18, 202539.9640.2139.7640.01665.3K
Feb 14, 202540.0940.1839.6939.861.18M
Feb 13, 202540.0340.6139.7240.061.76M
Feb 12, 202539.9840.4039.4040.142.66M
Feb 11, 202540.0040.0639.2739.281.04M
Feb 10, 202539.8640.4739.6340.101.52M
Feb 07, 202541.3841.4840.8541.341.31M
Feb 06, 202542.1142.8041.8042.442.85M
Feb 05, 202543.9344.0343.3543.801.53M
Feb 04, 202543.6943.9643.0343.361.23M
Feb 03, 202543.9744.2043.6543.841.23M
Jan 31, 202544.5645.0544.4144.64813.9K
Jan 30, 202544.0444.9043.8844.511.02M
Jan 29, 202544.8644.8643.5543.771.04M
Jan 28, 202547.3047.4446.4046.431.28M
Jan 27, 202547.4847.5746.5646.781.54M
Jan 24, 202546.8747.2846.7046.931.56M
Jan 23, 202548.6248.7146.7447.143.19M

Contact Details

Venlo, 5912 PL

Netherlands

Website: https://www.qiagen.comContact: 317 735 56600

About Company

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a strategic alliance agreement with Sysmex Corporation and OncXerna Therapeutics, as well as an agreement with Mirati. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

Company Information

Employees5700
Beta0.36
Sales or Revenue$1.97B
5Y Sales Change%0.333%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Diagnostics & Research

Frequently Asked Questions

What is the current Qiagen N.V. (QGEN) stock price?

Qiagen N.V. (NYSE: QGEN) stock price is $38.94 in the last trading session. During the trading session, QGEN stock reached the peak price of $39.46 while $38.85 was the lowest point it dropped to. The percentage change in QGEN stock occurred in the recent session was 0.95% while the dollar amount for the price change in QGEN stock was $0.37.

QGEN's industry and sector of operation?

The NYSE listed QGEN is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Qiagen N.V. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of QGEN?

Dr. Jonathan G. Sheldon Ph.D.
Senior Vice President of Qiagen Digital Insights Bus. Area
Dr. Roland Sackers
Chief Financial Officer, MD & Member of Management Board
Mr. Thierry Bernard
Chief Executive Officer, MD & Member of Management Board
Mr. Thomas Neidert
Vice President of Global Treasury
Mr. John Gilardi
Vice President of Corporation Communications & Investor Relations
Ms. Stephany Foster
Senior Vice President & Head of HR
Dr. Thomas Theuringer
Senior Director & Head of External Communications
Mr. Jean-Pascal Viola
Senior Vice President & Head of Molecular Diagnostics Bus. Area
Mr. Antonio Santos
Senior Vice President & Head of Global Operations
Dr. Thomas Schweins
Senior Vice President of Life Science Bus. Area

How QGEN did perform over past 52-week?

QGEN's closing price is 0.21% higher than its 52-week low of $38.49 where as its distance from 52-week high of $47.93 is -19.53%.

How many employees does QGEN have?

Number of QGEN employees currently stands at 5,700.

Link for QGEN official website?

Official Website of QGEN is: https://www.qiagen.com

How do I contact QGEN?

QGEN could be contacted at phone 317 735 56600 and can also be accessed through its website. QGEN operates from Hulsterweg 82, Venlo, 5912 PL, Netherlands.

How many shares of QGEN are traded daily?

QGEN stock volume for the day was 319.54K shares. The average number of QGEN shares traded daily for last 3 months was 1.07M.

What is the market cap of QGEN currently?

The market value of QGEN currently stands at $8.48B with its latest stock price at $38.94 and 217.68M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph